The World Health Organisation will this year start to work with scientists and drug developers to gather more information ...

Updated guidance on vascular cognitive impairment emphasizes executive function and processing speed, endorses brief, ...

HPV status, particularly combined p16 and HPV positivity, is vital for patient selection in de-escalation strategies for ...

New peer-reviewed research adds to substantial body of scientific evidence highlighting the safety of natural kratom leaf ...

Sevabertinib, targeting HER2 and EGFR mutations, received FDA breakthrough designation for HER2+ NSCLC, showing a 59% overall ...

Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show ...

Study in a Sentence: The U.S. Food and Drug Administration approved an Investigational New Drug (IND) application using efficacy data solely from Qureator’s human vascularized organoid model, moving ...

AFTER AMERICA, China is the world’s largest developer of new medicines. Its companies ran nearly a third of the planet’s clinical trials last year. That is up from just 5% a decade before (see chart 1 ...

The second Trump administration has been defined by widespread cuts to federal spending, including at the National Institutes of Health (NIH). A new analysis reveals that the termination of NIH grants ...

The Trump administration’s latest effort to lower drug costs is expanding to biosimilars, medications that are highly similar to biologic drugs made with or isolated from living organisms such as ...

Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and patient safety. Credit...Blake Cale Supported by By Walt Bogdanich Carson Kessler ...